-
1 Comment
Tianda Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 22.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Tianda Pharmaceuticals Limited's total revenue sank by 6.7% to $123M since the same quarter in the previous year.
Its net income has increased by 18.3% to $786K since the same quarter in the previous year.
Finally, its free cash flow fell by 744.5% to $-31M since the same quarter in the previous year.
Based on the above factors, Tianda Pharmaceuticals Limited gets an overall score of 3/5.
| ISIN | KYG887471038 |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Exchange | HK |
| CurrencyCode | HKD |
| Market Cap | 301M |
|---|---|
| Target Price | None |
| Dividend Yield | 1.7% |
| Beta | -0.15 |
| PE Ratio | None |
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine, Pharmaceuticals and Medical Technologies, and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products focusing on cardiovascular and cerebrovascular chronic diseases, respiratory infections, and pediatric diseases. In addition, the company trades agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0455.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
